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journal homepage: www.t jog-onl ine.comEditorialVisfatin, breastfeeding, and breast cancerBreast cancer is a big health issue in theworld, including Taiwan,
since the actual incidence of invasive breast cancer increased signif-
icantly. In 2011, the incidence rate (IR) of breast cancer was 64.3 per
100,000women after adjustment for agecontributing to amortality
rate of 15.99 per 100,000 women, which represented the fourth
highest mortality rate of all cancer death, and the IR of breast can-
cer seemed to be continuously elevated [1,2]. Although hereditary
factors play an important role in development of breast cancer
[3], there is no doubt that the link between hormones, cytokines,
metabolic parameters, environmental factors, and reproductive
history and breast cancer growth and development has been recog-
nized for more than a century [4,5].
Breastfeeding not only decreases the risk of developing breast
cancer but also decreases the risk of recurrence in women treated
for breast cancer. A recent United States study analyzed information
on 1636 women with breast cancer from two prospective breast
cancer cohorts, and results showed that women who had ever
breast fed had a 30% lower risk of recurrence than women who
had not [hazard ratio (HR), 0.70; 95% conﬁdence interval (CI),
0.53e0.93], and an even lower risk was found in those who had
breast fed for 6 months or longer (HR 0.63, 95% CI 0.46e0.87;
p trend ¼ 0.01) [6]. The beneﬁts of breastfeeding are also signiﬁ-
cantly evident in the declined breast cancer deaths [6]. All sug-
gested that breastfeeding may set up a molecular environment
that makes the tumor less likely to metastasize, treatable with hor-
monal therapy such as tamoxifen, and generally have better out-
comes. In the past issue of the Taiwanese Journal of Obstetrics and
Gynecology, Dr. Shen et al [7] have an article addressing this impor-
tant topicdbreastfeeding effects on visfatin levels in postpartum
women. Results showed that women with continuous breastfeed-
ing had higher levels of visfatin than those without breastfeeding
and a longer duration of breastfeeding showed a higher level of vis-
fatin [7].
The authors highlighted the value of this article, because results
showed that signiﬁcant correlations were found between visfatin
and hemoglobin A1c (r ¼ 0.425, p ¼ 0.022) at the 2nd week point
and triglycerides (r¼0.387, p¼ 0.038) at the 16th week [7]. There-
fore, their ﬁndings might shed a light on the necessity of further
exploration of the mechanisms through which lactation may inﬂu-
ence the occurrence of diabetes. We congratulate the authors on
their success and also appreciate their contribution to this ﬁeld.
Dr. Shen et al's [7] report favored the beneﬁts of breastfeeding
on metabolic status; however, their results might conﬂict with
the recent understanding of the relationship between serum
levels of visfatin and risk of breast cancer and other cancers, such
as endometrial cancer and colon cancer. In addition, visfatinhttp://dx.doi.org/10.1016/j.tjog.2015.05.001
1028-4559/Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Publishedplays an important role in a variety of metabolic and stress re-
sponses, as well as in cellular energy metabolism as nicotinamide
phosphoribosyl-transferase and contributes to the generation of
nicotinamide adenine dinucleotide biosynthesis, which was signif-
icantly upregulated by a hypoxic microenvironment [8]. All hinted
that visfatin might be important during the stress situation.
Although not all, stress-related proteins are often reported to corre-
latewithmany unhealthy situations, including development of can-
cer and chronic illness [9]. Furthermore, a previous study showed a
higher visfatin expression in breast cancer tissue correlating with
more malignant cancer behavior, and estrogen receptor (ER) and
progesterone receptor (PR) negativity, indicators of poor prognosis
and survival [8], but Dr. Shen et al [7] found that continuous breast-
feeding for at least 16 weeks could induce increasing visfatin levels.
Does the higher visfatin level increase the risk of development
of breast cancer? Based on Dr. Shen et al's [7] report, it might be
against the positive correlation between visfatin level and risk of
breast cancer. Therefore, we would like to introduce the mecha-
nisms of visfatin in cancers. Several pathways are suggested,
including visfatin activating cell cycle progression by upregulation
of cyclins, other cyclin-dependent kinases, increased synthesis of
genes playing a signiﬁcant role in tumor-related angiogenesis,
such as vascular epidermal growth factor, in metastases and inva-
sion, such as matrix metalloprotease [10]. Unlike the above ﬁnd-
ings, the role of visfatin on normal and abnormal metabolic
function is relatively unclear. Dr. Shen et al's [7] report might sup-
port our understanding of the positive correlation between
abnormal metabolism status and an increased risk of many
hormone-dependent malignant tumors, including breast cancer, if
an increased visfatin level might be against the metabolic diseases,
such as diabetes mellitus.
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